Choo Heng Tong

Heng Tong holds dual appointments as Executive Vice President (Investments) at EDBI and BioOne Capital, its dedicated biomedical sciences investment subsidiary. He is responsible for EDBI’s strategic growth capital for local companies as well as venture investments in biomedical sciences, and also oversee EDBI’s operations in the United States. He has over 15 years of experience in investments and industry development; including M&As, strategic planning, business development, and international growth into new markets, involving both multi-nationals and start-up organizations. He was previously with Singapore Economic Development Board where he worked with various industries such as biotechnology, pharmaceutical, and engineering companies to grow their business and operations in Asia. Currently, Heng Tong serves on the board of Maccine Pte Ltd, SBio Pte Ltd, QT Vascular Pte Ltd, Jurong Aromatics Corporation Pte Ltd and SPRING’s Growth Enterprise Fund Pte Ltd.

Choo Heng Tong is the Executive Vice President, Investments at EDBI, based in Asia. With a background in Financial Services, Choo Heng Tong has a rich history of leadership and innovation. Choo Heng Tong studied M.Eng Aeronautical Engineering @ Imperial College London. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.